Annual CFO
-$21.69 M
-$6.90 M-46.70%
December 31, 2023
Summary
- As of February 8, 2025, MXCT annual cash flow from operations is -$21.69 million, with the most recent change of -$6.90 million (-46.70%) on December 31, 2023.
- During the last 3 years, MXCT annual CFO has fallen by -$12.90 million (-146.93%).
- MXCT annual CFO is now -11914.40% below its all-time high of -$180.50 thousand, reached on December 31, 2015.
Performance
MXCT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$4.39 M
+$443.00 K+9.16%
September 30, 2024
Summary
- As of February 8, 2025, MXCT quarterly cash flow from operations is -$4.39 million, with the most recent change of +$443.00 thousand (+9.16%) on September 30, 2024.
- Over the past year, MXCT quarterly CFO has increased by +$3.85 million (+46.70%).
- MXCT quarterly CFO is now -547.60% below its all-time high of $981.00 thousand, reached on December 31, 2023.
Performance
MXCT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$18.81 M
+$3.85 M+16.98%
September 30, 2024
Summary
- As of February 8, 2025, MXCT TTM cash flow from operations is -$18.81 million, with the most recent change of +$3.85 million (+16.98%) on September 30, 2024.
- Over the past year, MXCT TTM CFO has increased by +$9.95 million (+34.59%).
- MXCT TTM CFO is now -324.91% below its all-time high of -$4.43 million, reached on June 30, 2022.
Performance
MXCT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MXCT Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -46.7% | +46.7% | +34.6% |
3 y3 years | -146.9% | +27.9% | -27.2% |
5 y5 years | -106.8% | +27.9% | -27.2% |
MXCT Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -103.1% | at low | -547.6% | +58.4% | -324.9% | +34.6% |
5 y | 5-year | -146.9% | at low | -547.6% | +58.4% | -324.9% | +34.6% |
alltime | all time | <-9999.0% | at low | -547.6% | +58.4% | -324.9% | +34.6% |
MaxCyte Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$4.39 M(-9.2%) | -$18.81 M(-17.0%) |
Jun 2024 | - | -$4.83 M(-54.2%) | -$22.66 M(-18.9%) |
Mar 2024 | - | -$10.56 M(-1176.9%) | -$27.93 M(+28.8%) |
Dec 2023 | -$21.69 M(+46.7%) | $981.00 K(-111.9%) | -$21.69 M(-24.6%) |
Sep 2023 | - | -$8.24 M(-18.5%) | -$28.75 M(+8.8%) |
Jun 2023 | - | -$10.11 M(+133.7%) | -$26.44 M(+71.5%) |
Mar 2023 | - | -$4.32 M(-29.0%) | -$15.41 M(+4.3%) |
Dec 2022 | -$14.78 M(+38.4%) | -$6.09 M(+2.8%) | -$14.78 M(+53.1%) |
Sep 2022 | - | -$5.92 M(-744.6%) | -$9.66 M(+118.2%) |
Jun 2022 | - | $918.60 K(-124.9%) | -$4.43 M(-54.5%) |
Mar 2022 | - | -$3.69 M(+284.7%) | -$9.73 M(-8.9%) |
Dec 2021 | -$10.68 M | -$960.30 K(+39.1%) | -$10.68 M(+9.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | -$690.50 K(-84.3%) | -$9.72 M(+7.6%) |
Jun 2021 | - | -$4.39 M(-5.5%) | -$9.03 M(+94.5%) |
Mar 2021 | - | -$4.64 M | -$4.64 M |
Dec 2020 | -$8.78 M(-0.2%) | - | - |
Dec 2019 | -$8.80 M(-16.1%) | - | - |
Dec 2018 | -$10.49 M(+8.4%) | - | - |
Dec 2017 | -$9.68 M(+314.4%) | - | - |
Dec 2016 | -$2.33 M(+1193.6%) | - | - |
Dec 2015 | -$180.50 K(-90.6%) | - | - |
Dec 2014 | -$1.93 M(+245.2%) | - | - |
Dec 2013 | -$557.80 K(-73.8%) | - | - |
Dec 2012 | -$2.13 M | - | - |
FAQ
- What is MaxCyte annual cash flow from operations?
- What is the all time high annual CFO for MaxCyte?
- What is MaxCyte annual CFO year-on-year change?
- What is MaxCyte quarterly cash flow from operations?
- What is the all time high quarterly CFO for MaxCyte?
- What is MaxCyte quarterly CFO year-on-year change?
- What is MaxCyte TTM cash flow from operations?
- What is the all time high TTM CFO for MaxCyte?
- What is MaxCyte TTM CFO year-on-year change?
What is MaxCyte annual cash flow from operations?
The current annual CFO of MXCT is -$21.69 M
What is the all time high annual CFO for MaxCyte?
MaxCyte all-time high annual cash flow from operations is -$180.50 K
What is MaxCyte annual CFO year-on-year change?
Over the past year, MXCT annual cash flow from operations has changed by -$6.90 M (-46.70%)
What is MaxCyte quarterly cash flow from operations?
The current quarterly CFO of MXCT is -$4.39 M
What is the all time high quarterly CFO for MaxCyte?
MaxCyte all-time high quarterly cash flow from operations is $981.00 K
What is MaxCyte quarterly CFO year-on-year change?
Over the past year, MXCT quarterly cash flow from operations has changed by +$3.85 M (+46.70%)
What is MaxCyte TTM cash flow from operations?
The current TTM CFO of MXCT is -$18.81 M
What is the all time high TTM CFO for MaxCyte?
MaxCyte all-time high TTM cash flow from operations is -$4.43 M
What is MaxCyte TTM CFO year-on-year change?
Over the past year, MXCT TTM cash flow from operations has changed by +$9.95 M (+34.59%)